Sharing our perspectives

We publish Investment Stewardship Insights to provide investors, portfolio companies, and other interested parties with timely perspectives on important governance topics and key votes.

Voting insights

December 19, 2024

Executive compensation at Beyond, Inc.

This piece provides rationale for how the Vanguard-advised funds voted on an executive pay proposal at Beyond, Inc.

Read more
December 16, 2024

Say on Pay at Netflix, Inc.

This piece provides rationale for how the Vanguard-advised funds voted on an executive pay proposal at Netflix, Inc.

Read more
November 25, 2024

Reelection of zombie director at Keros Therapeutics, Inc.

This piece provides rationale for how the Vanguard-advised funds voted on director election proposals at Keros Therapeutics, Inc.

Read more
November 14, 2024

Shareholder proposal regarding director climate-related competencies at Mitsubishi UFJ Financial Group, Inc.

This piece provides rationale for how the Vanguard-advised funds voted on a shareholder proposal to amend articles of incorporation at Mitsubishi UFJ Financial Group, Inc.

Read more
October 23, 2024

Say on Pay at The Carlyle Group Inc.

This piece provides rationale for how the Vanguard-advised funds voted on an executive pay proposal at The Carlyle Group Inc.

Read more
August 29, 2024

Securities lending and proxy voting at Vanguard

This piece outlines how Investment Stewardship considers securities lending in the context of proxy voting for Vanguard-advised funds.

Read more
August 14, 2024

Stock plan proposal at Moelis & Company

This piece provides rationale for how the Vanguard-advised funds voted on a stock plan proposal at Moelis.

Read more
July 30, 2024

Key committee independence at WELL Health Technologies Corp.

This piece provides rationale for how the Vanguard-advised funds voted on director elections at WELL Health.

Read more
July 29, 2024

Director capacity and commitments at the Beauty Health Company

This piece provides rationale for how the Vanguard-advised funds voted on director elections at BeautyHealth.

Read more
July 29, 2024

Discharge of board directors at Grifols SA

This piece provides rationale for how the Vanguard-advised funds voted on a proposal to discharge directors at Grifols.

Read more
July 26, 2024

Shareholder proposals regarding lobbying activities and political expenditures at Charter Communications, Inc.

This piece provides rationale for how the Vanguard-advised funds voted on two shareholder proposals related to the company’s lobbying activities and political expenditures at Charter Communications.

Read more
July 26, 2024

Amending company articles to enable conversion to a B Corp at Assura plc

This piece provides rationale for how the Vanguard-advised funds voted on proposed amendments to company Articles of Association to enable registration as a B Corporation at Assura plc.

Read more
July 24, 2024

Shareholder proposal requesting the removal of registration and voting rights restrictions at Baloise

This piece provides rationale for how the Vanguard-advised funds voted on shareholder proposals requesting the removal or registration and voting rights restrictions at Baloise.

Read more
July 24, 2024

Renewing takeover defense plans at Nisshin Seifun Group Inc.

This piece provides rationale for how the Vanguard-advised funds voted on a proposal to approve the renewal of the company’s takeover defense plan.

Read more
July 12, 2024

Shareholder proposal requesting a report on risks created by diversity, equity, and inclusion efforts at Citigroup Inc.

This piece provides rationale for how the Vanguard-advised funds voted on a shareholder proposal requesting a report on risks created by DEI efforts at Citigroup Inc.

Read more
July 3, 2024

Shareholder proposal regarding enhanced board skills and diversity disclosure at NextEra Energy, Inc.

This piece provides rationale for how the Vanguard-advised funds voted on shareholder proposals requesting disclosure of a board skills and diversity matrix at NextEra Energy, Inc.

Read more
June 24, 2024

Shareholder proposal requesting Scopes 1 and 2 emissions targets at Kinder Morgan, Inc.

This piece provides rationale for how the Vanguard-advised funds voted on a climate-related shareholder proposal at Kinder Morgan.

Read more
June 14, 2024

Redomestication and executive pay proposals at Tesla, Inc.

This piece provides rationale for how the Vanguard-advised funds voted on redomestication and executive pay proposals at Tesla.

Read more
June 12, 2024

Shareholder proposal requesting disclosure of Scope 3 emissions at Enbridge Inc.

This piece provides rationale for how the Vanguard-advised funds voted on a climate-related shareholder proposal at Enbridge.

Read more
June 12, 2024

Amendments to voting rights at Veolia

This piece provides rationale for how the Vanguard-advised funds voted on a binding management proposal seeking an amendment of the company’s articles of association.

Read more
May 31, 2024

Director elections at Exxon Mobil Corporation

This piece provides rationale for how the Vanguard-advised funds voted on director elections at Exxon.

Read more
May 28, 2024

Contested director elections at Norfolk Southern Corporation

This piece provides rationale for how the Vanguard-advised funds voted on contested director elections at Norfolk Southern.

Read more
May 28, 2024

Vanguard’s approach to climate risk governance

This piece outlines what Vanguard-advised funds look for with respect to governance of material climate risks.

Read more
22 May 2024

Board declassification proposal at Meritage Homes Corporation

This piece provides rationale for how the Vanguard-advised funds voted on a shareholder proposal to declassify the board at Meritage Homes.

Read more
17 May 2024

Executive pay benchmarking at AstraZeneca

This piece provides rationale for how the Vanguard-advised funds voted on the directors' remuneration policy and a related amendment to the performance share plan

Read more
17 May 2024

Materialized risks at Hyundai Elevator

This piece provides rationale for how the Vanguard-advised funds voted on the 2024 re-election of directors.

Read more
15 May 2024

Materialized risks at Hyosung Corporation

This piece provides rationale for how the Vanguard-advised funds voted on the 2024 re-election of directors.

Read more
13 May 2024

Say on Pay at Broadcom Inc.

This piece provides rationale for how the Vanguard-advised funds voted on the executive compensation plan at Broadcom.

Read more
10 May 2024

Say on Climate proposal at Woodside Energy Group

This piece provides rationale for how the Vanguard-advised funds assessed the Climate Transition Action Plan and Progress Report at Woodside Energy Group.

Read more
May 7, 2024

Our executive pay philosophy

This piece outlines how Vanguard’s Investment Stewardship team approaches executive pay.

Read more
18 April 2024

Say on Pay at TransDigm Group Inc.

This piece provides rationale for how the Vanguard-advised funds voted on the executive compensation plan at TransDigm.

Read more
15 April 2024

Director independence at Bertrandt

This piece provides rationale for how the Vanguard-advised funds voted on the director election proposals at Bertrandt.

Read more
05 April 2024

Say on Pay proposal at Raymond James

This piece provides rationale for how the Vanguard-advised funds voted on the executive compensation plan at Raymond James.  

Read more
02 April 2024

Contested director election at The Walt Disney Company

This piece provides rationale for how the Vanguard-advised funds voted on contested director elections at The Walt Disney Company.

Read more
08 March 2024

Adoption of an exclusive forum provision at Duke Energy Corporation

This piece provides rationale for how the Vanguard-advised funds assessed the adoption of an exclusive forum provision at Duke Energy Corporation.

Read more
26 February 2024

Say on Climate proposal at Sasol

This piece provides rationale for how the Vanguard-advised funds voted on a management proposal requesting that shareholders approve the company's climate change report.

Read more
26 February 2024

Stock option exchange proposal at SAGE Therapeutics

This piece provides rationale for how the Vanguard-advised funds voted on the company's stock option exchange program.

Read more
23 February 2024

Cyber risk at Medibank

This piece provides rationale for how the Vanguard-advised funds voted on director re-elections following a cyberattack at Medibank. 

Read more